27 Jul 2026
Fierce Biotech featured the launch of the Marker by Labcorp™ Genetic Health Panel, a new offering available through Labcorp OnDemand designed to help consumers better understand inherited risks associated with more than 100 medically actionable health conditions. The panel analyzes 163 genes inked to hereditary cancer, cardiovascular conditions and metabolic conditions, and includes access to licensed genetic counselors who can help consumers understand their results and discuss appropriate next steps. The offering is backed by Labcorp’s established expertise in clinical genetic testing through Labcorp Genetics and its Invitae genetic testing capabilities.
In the article, Dr. Leslie Saltzman, vice president of consumer health solutions at Labcorp, highlighted the importance of expanding access to genetic health insights. She noted that the Marker by Labcorp Genetic Health Panel combines genetic testing, genetic counseling support and Labcorp’s genetics expertise into a single, convenient healthcare experience.
The launch reflects Labcorp’s commitment to making genetic health information more accessible and empowering consumers with insights that may help them better understand potential inherited health risks.
Read the full article at Fierce Biotech to learn more.